Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Immuno-Oncology
Teon Tx and MSD Partner in Oral IO Clinical Trial
Teon Tx and MSD will partner to study a combination of a new immune-modifier and existing anti-PD-1 immune checkpoint inhibitor.
The Race for an RSV Vaccine Approval
Things are heating up in the race to pinch the first FDA approval of an RSV vaccine, as Moderna joins Pfizer and GSK in the running.
Funding Boost Announced for Experimental Cancer Medicine Centres
Potential treatments which may benefit from the funding increase include CAR-T cell therapies and checkpoint inhibitors, with the end goal of clinical use in cancer patients.
Immuno-Oncology
New Funding Given to Network of Experimental Cancer Medicine Centres
The ECMC network will enter new partnerships to increase the availability of clinical trials for cancer patients.
Antibody & Protein Engineering
FDA Grant Approval for Alzheimer's Drug Leqembi
The US regulators have approved Eisai and Biogen’s Alzheimer’s drug, lecanemab, a “landmark” moment for the disease.
Peptide Chemistry
The Future of Peptide Chemistry and Sustainability
The peptide market is continually developing, but how are manufacturers responding to its new requirements and altering the landscape of peptide manufacturing?
Immuno-Oncology
Approaches to Combinational Immunotherapies: From Clinic to Approval
Our panel discussing combination therapeutics addresses challenges, modelling, and the importance of biomarkers.
Good Manufacturing Practices: Overcoming Regulatory Approval Hurdles
Securing regulatory approval is often the end goal in the development of a new therapeutic product. But what steps can be taken to avoid some of the common curveballs encountered in the industry?
Drug Discovery & Development
Antibody Discovery by Single B Cell Screening on Beacon®
On-Demand Webinar featuring Dr Amy Sheng, Technical Account Manager at Sino Biological
3D Cell Culture
In Conversation With...Stefan Przyborski, Professor, Durham University
In this video Q&A we discuss Stefan's recent work with bioengineered human tissues and the challenges to adopting 3D cell culture technologies in research.
Drug Discovery & Development
Experts Discuss Developing Oncolytic Virus Immunotherapy
Our November Immuno-Oncology Discussion Group brought together experts in the field of oncolytic virus development to discuss engineering and translational strategies of the field
3D Cell Culture
Apical-Out Organoids: A Novel Strategy to Control the Polarity of Organoids Closing
Genentech are developing several complex gastrointestinal in vitro models, including the innovative apical-out organoids.